Aztreonam avibactam vs cefiderocol is an important clinical comparison in the treatment of difficult-to-treat Gram-negative infections. Both agents have activity against selected resistant pathogens, but they work through different mechanisms and have different clinical evidence bases. Although both...
Aztreonam avibactam drug interactions are an important consideration when this intravenous antibacterial combination is used with other medicines. Current prescribing information identifies particular concern with organic anion transporter (OAT) 1 and OAT 3 inhibitors such as probenecid, while...
Aztreonam avibactam side effects can range from commonly reported reactions such as diarrhea, anemia, hypokalemia and fever to important safety concerns involving hypersensitivity, serious skin reactions, hepatic effects and Clostridioides difficile-associated diarrhea. Understanding the safety profile of aztreonam-avibactam...
Aztreonam-avibactam renal dosing is based on estimated creatinine clearance (CrCl). As renal function declines, the loading dose, maintenance dose, and dosing interval may need to change. Current U.S. prescribing information uses Cockcroft-Gault estimated CrCl to determine the renal...
Aztreonam-avibactam is administered by intravenous infusion, and the dosing regimen depends on the approved indication, renal function, and the regulatory product information being followed. For healthcare professionals researching aztreonam avibactam dosage, it is important to distinguish the standard...
